Article

STAAR Surgical announces management additions, promotions

The company promotes two and adds another employee as it names three vice presidents.

Monrovia, CA-STAAR Surgical Co. has announced several additions to its senior management team.

James Francese has joined the company as vice president of global development; Robin Hughes has been named vice president of research and development, regulatory and quality; and Craig Felberg has been named vice president of business development.

“These leadership transitions are designed to help fuel our revenue growth in three ways: more effectively and aggressively market STAAR products globally, bring new products to market more quickly, and evaluate additional new technologies and business opportunities [that] will allow us to grow within our area of strategic focus,” said Barry Caldwell, STAAR chief executive officer.

Francese has 22 years of experience in ophthalmology, including 14 years marketing surgical products with Abbott Medical Optics (AMO) and Allergan. During his time at AMO, he served as head of marketing, Americas, for all surgical, refractive, and corneal products; head of global corneal marketing, responsible for all consumer products; and vice president of the Asia Pacific region.

Hughes has more than 20 years of experience in the ophthalmic industry, including the past 5 years as vice president of global marketing at STAAR.

Felberg has 30 years of experience in the ophthalmic surgical business, including the past 5 years as vice president of research and development at STAAR.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.